Detailed Information on Publication Record
1997
T cell activity and cytokine production in X-linked agammaglobulinemia: Implications for vaccination strategies
PLEBANI, A., MB. FISCHER, A. MEINI, M. DUSE, Vojtěch THON et. al.Basic information
Original name
T cell activity and cytokine production in X-linked agammaglobulinemia: Implications for vaccination strategies
Name in Czech
T buněčná aktivita a cytokinová produkce u X vázané agamaglobulinemie: důsledky pro vakcinační strategii
Authors
PLEBANI, A. (380 Italy), MB. FISCHER (40 Austria), A. MEINI (380 Italy), M. DUSE (380 Italy), Vojtěch THON (203 Czech Republic, guarantor) and MM. EIBL (40 Austria)
Edition
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 1018-2438
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.721
RIV identification code
RIV/00216224:14110/97:00035798
Organization unit
Faculty of Medicine
UT WoS
A1997XR99700014
Keywords (in Czech)
XLA; vakcinace
Keywords in English
X linked agammaglobulinemia; vaccine; cytokines; cell mediated immunity
Tags
International impact, Reviewed
Změněno: 26/6/2009 00:17, prof. MUDr. Vojtěch Thon, Ph.D.
V originále
In the 5 X-linked agammaglobulinelnia (XLA) patients studied we show that memory T cells are present and that T lymphocytes proliferate normally to mitogens, monoclonal antibodies and, in particular, to recall antigens demonstrating normal in vivo T cell priming despite the absence of B cells. Furthermore, in vitro T cell activation in response to both T cell receptor-independent and T-cell receptor-dependent signals leads to a pattern of cytokine production characteristic of primed T cells and necessary for normal T cell function. These data are in good agreement with results obtained in gene-targeted mice and further support the concept that the absence of B cells does not impair induction of in vivo T cell memory and effector function which is generally considered to be of great importance in conferring protection against viral infections. Thus, while there is no risk of inducing infections in XLA patients by administering vaccines containing killed viruses or recombinant viral proteins, stimulation of T cell immunity by such vaccines may be of potential benefit particularly in the defense against infections with viruses such as the hepatitis B virus to which hypogammaglobulinemic patients are particularly exposed.
In Czech
T buněčná aktivita a cytokinová produkce u X vázané agamaglobulinemie: důsledky pro vakcinační strategii.